Adamis Pharmaceuticals Announces NIH Grant Funding For Treatment Of Alcohol Use Disorder, Size Not Disclosed
Portfolio Pulse from Bill Haddad
Adamis Pharmaceuticals has received an undisclosed amount of grant funding from the National Institutes of Health (NIH) for the development of a treatment for alcohol use disorder.
June 26, 2023 | 11:37 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Adamis Pharmaceuticals (ADMP) has been granted funding by the NIH for the development of a treatment for alcohol use disorder, potentially boosting its R&D capabilities.
The NIH grant funding will provide Adamis Pharmaceuticals with additional resources to develop a treatment for alcohol use disorder. This could potentially lead to a new revenue stream for the company and enhance its R&D capabilities, positively impacting its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100